Mohamed Rajik

Title: Innovations of Mohamed Rajik in Avian Influenza Research

Introduction

Mohamed Rajik is an accomplished inventor based in Serdang, Malaysia. He has made significant contributions to the field of virology, particularly in the development of therapeutic agents against avian influenza.

Latest Patents

His notable patent is titled "Antiviral peptide against avian influenza virus H9N2." This invention relates to recombinant phages carrying fusion peptides that bind to avian influenza virus (AIV). These phages serve as diagnostic reagents, replacing anti-AIV antibodies by competing for binding sites on the virus. The synthetic peptides with the sequence CNDFRSKTC, in either linear or cyclic conformations, or fusion phages bearing these peptides, have shown effectiveness in inhibiting AIV propagation in embryonated eggs and MDCK cell lines. Therefore, they may be utilized as therapeutic agents to control, treat, and eradicate bird flu caused by avian influenza virus.

Career Highlights

Mohamed Rajik is affiliated with Universiti Putra Malaysia, where he continues to engage in innovative research. His work has garnered attention for its potential impact on public health and disease management.

Collaborations

He has collaborated with notable colleagues, including Khatijah Mohd Yusoff and Abdul Rahman Omar, contributing to the advancement of research in his field.

Conclusion

Mohamed Rajik's innovative work in developing antiviral peptides against avian influenza showcases his commitment to addressing significant health challenges. His contributions are vital in the ongoing fight against viral infections.